Eberhard Pfaff

Title: Eberhard Pfaff: Innovator in Immunogenic Peptides

Introduction

Eberhard Pfaff is a notable inventor based in Schwaigern, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccines. His work focuses on innovative solutions to combat viral diseases, showcasing his expertise and dedication to scientific advancement.

Latest Patents

Eberhard Pfaff holds a patent for "Immunogenic peptides of foot-and-mouth disease viruses." This invention relates to an FMDC vaccine based on peptides that have a sequence of at least 8 amino acids. These peptides correspond to a partial sequence of the non-structural protein region of FMDV. They were selected based on immunoreactivity with FMDV-specific antibodies or T lymphocytes. The patent emphasizes the production and use of these peptides in vaccine development.

Career Highlights

Eberhard Pfaff is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His role at Bayer has allowed him to contribute to groundbreaking research and development in vaccine technology. His innovative approach has positioned him as a key figure in the fight against foot-and-mouth disease.

Collaborations

Eberhard Pfaff has collaborated with esteemed colleagues, including Roberto Correa and Hans-Robert Hehnen. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to significant advancements in immunogenic peptide technology.

Conclusion

Eberhard Pfaff's contributions to the field of immunology, particularly through his patent on immunogenic peptides, highlight his role as an innovator in vaccine development. His work continues to impact the scientific community and the fight against viral diseases.